Press Releases

Shareholders are encouraged to vote well in advance of the proxy voting deadline on April 10, 2024 at 1:00 p.m. Eastern Time (Toronto time) For any questions or assistance with voting, shareholders should contact Laurel Hill Advisory Group at 1-877-452-7184 (North American Toll Free) or 1‑416‑304‑0211 (Outside North America), or by email at assistance@laurelhill.com. SMITHS FALLS, ONTARIO APRIL 1, 2024 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED, Nasdaq: CGC) is pleased to announce that Institutional Shareholder Services (“ISS”), in its report issued on Canopy Growth’s special meeting of shareholders scheduled for April 12, 2024, has recommended…

Removal of narcotic status for cannabis expected to accelerate growth of the German medical cannabis market SMITHS FALLS, ON, MARCH 22, 2024 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, celebrates the German government’s final approval legalizing cannabis, as well as advancing a clear victory for enhanced medical cannabis access. As of April 1, 2024, cannabis will officially be recognized as a non-narcotic in Germany, marking a monumental shift in the legal treatment and cultural acceptance of cannabis. This landmark decision will enable adult German consumers to consume cannabis legally…

Shareholders are encouraged to vote well in advance of the proxy voting deadline on April 10, 2024 at 1:00 p.m. Eastern Time (Toronto time) For any questions or assistance with voting, shareholders should contact Laurel Hill Advisory Group at 1-877-452-7184 (North American Toll Free) or 1‑416‑304‑0211 (Outside North America), or by email at assistance@laurelhill.com. SMITHS FALLS, ONTARIO MARCH 14, 2024 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED, Nasdaq: CGC) today announced that independent proxy advisory firm Glass Lewis & Co. (“Glass Lewis”), in its report issued on Canopy Growth’s special meeting of shareholders scheduled for April…

Shareholders to vote on the creation of a new class of Exchangeable Shares, which is expected to be a critical step in strategy to accelerate Canopy Growth’s entry into the over $50B1 S. THC market. For any questions or assistance with voting, shareholders should contact Laurel Hill Advisory Group at 1-877-452-7184 (North American Toll Free) or 1‑416‑304‑0211 (Outside North America), or by email at assistance@laurelhill.com. FEBRUARY 20, 2024 SMITHS FALLS, ON— Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED, Nasdaq: CGC) announced today that the Company will hold a special meeting (the “Meeting”) of shareholders at 1:00PM…

Canada adult-use cannabis business-to-business net revenue up 9% year-over-year; Canada medical cannabis net revenue up 11% year-over-year Focused execution drove sustained margin improvement with second quarter of consolidated gross margins exceeding 30% Canopy USA strategy moving forward; special shareholder meeting scheduled for April 12, 2024 Read the full PDF Press Release Here SMITHS FALLS, ON, February 9, 2024 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (Nasdaq: CGC) today announces its financial results for the third quarter ended December 31, 2023. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. Highlights…

Smiths Falls, ON, January 26, 2024 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the third quarter fiscal year 2024 ended December 31, 2023 before financial markets open on February 9, 2024. Following the release of its third quarter fiscal year 2024 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO on February 9, at 10AM Eastern Time. Webcast Information A live audio webcast will be available at: https://app.webinar.net/GZqr9ALP1XV Replay Information A replay will be accessible by webcast until 11:59 PM ET on…

SMITHS FALLS, ON, January 24, 2024 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, today announced the introduction of new product offerings across the Company’s adult use and medical cannabis portfolio, including new Tweed softgels and oils featuring minor cannabinoids, a large format flower offering from Tweed, as well as new medical exclusive pre-roll products from 7ACRES and Spectrum Therapeutics. “In addition to launching new flower products, we’re making it easier to access CBD and minor cannabinoids in convenient oil and softgel formats to support wellness-minded consumers looking to start the…

SMITHS FALLS, ON. January 18, 2024 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), today announced that it has entered into subscription agreements (the “Subscription Agreements”), dated as of January 18, 2024, with certain institutional investors (the “Investors”) in a private placement offering (the “Offering”) of 8,158,510 units (“Units”) at a price per Unit of US$4.29 for aggregate gross proceeds of approximately US$35 million. The purpose of the Offering is to provide the Company with additional liquidity to further strengthen Canopy Growth’s financial position. Proceeds are expected to be used to pay down debt, which…

SMITHS FALLS, ON. January 9, 2024 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), today announced that it has entered into subscription agreements (the “Subscription Agreements”), dated as of January 9, 2024, with certain institutional investors (the “Investors”) in a private placement offering (the “Offering”) of 6,993,007 units (“Units”) at a price per Unit of US$4.29 for aggregate gross proceeds of approximately US$30,000,000 The purpose of the Offering is to provide the Company with additional liquidity of US$30MM to further strengthen Canopy Growth’s financial position. Proceeds are expected to be used to pay down debt,…

Divestiture of the skincare and wellness brand is aligned with Canopy Growth’s focus on North American cannabis operations SMITHS FALLS, ON and LONDON, UK – December 18th, 2023 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) today announced that the Company has completed the divestiture of its This Works skincare and wellness brand to Inspirit Capital, a London-based investment firm. Headquartered in London, England, This Works offers a range of high-quality natural skincare and sleep solution products to consumers around the world. In accordance with the completed sale agreement, This Works’ leadership, staff, and intellectual…

Shares will be consolidated at a 1 for 10 ratio Action expected to allow the Company to regain compliance with Nasdaq minimum bid price requirement SMITHS FALLS, ON — December 13, 2023 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) announced today that the Company’s board of directors has approved the consolidation (the “Consolidation”) of the Company’s issued and outstanding common shares (the “Common Shares”) on the basis of one (1) post-Consolidation Common Share for every ten (10) pre-Consolidation Common Shares. The Consolidation is being implemented to ensure that the Company continues to comply with…

Realization of sale proceeds further strengthens Canopy Growth’s balance sheet Completed transactions further advances Canopy Growth’s cannabis-focused, asset-light operating model SMITHS FALLS, ON – December 1, 2023 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) today provided an update that pursuant to the proceedings under the Companies’ Creditors Arrangement Act (the “CCAA”) involving BioSteel Sports Nutrition Inc. (“BioSteel Canada”), that two sale transactions transferring the assets of BioSteel Canada and BioSteel Manufacturing, LLC (“BioSteel Manufacturing”) have been completed for aggregate gross proceeds of $30.4 million. Pursuant to the CCAA court-ordered sale and investment solicitation process,…